Beyond GLP-1s: Are You Overlooking Savings Opportunities in Diabetes Medications?


GLP-1s are getting plenty of attention. But what about the rest of your diabetes medication spend?
GLP-1s are dominating conversations about pharmacy spend. But could that attention be overshadowing other opportunities to save across diabetes medications, from insulin to oral treatments?
For members, affordability is a real concern. In an American Diabetes Association survey, 46% of respondents reported spending more than $100 a month on insulin, while 41% said they had rationed, delayed, or skipped insulin or treatment because of cost.
For plan sponsors, the question is: How many opportunities to lower diabetes medication costs are being identified – and how many are actually being realized?
In honor of American Diabetes Month, we're exploring where those opportunities may be hiding and how Rx Navigation can help turn them into measurable savings.
Where Could Diabetes Medication Savings Be Hiding?
Diabetes medications aren't one-size-fits-all. Neither are their costs.
What an employer or member pays for a prescription can vary depending on the medication, pharmacy, plan coverage, and available treatment options. That means opportunities to save may exist across several categories:
Insulin: Different insulin products can carry different costs depending on the member's pharmacy benefits and clinical needs.
Oral diabetes medications: Lower-cost, clinically appropriate alternatives may be available depending on the prescribed medication and plan coverage.
GLP-1 medications: Differences in pricing, coverage, and available treatment options may create opportunities to evaluate costs.
Of course, not every prescription has a lower-cost alternative, and any medication change requires the prescribing provider's approval.
But knowing where opportunities may exist is only the beginning. The bigger challenge is making sure those opportunities don't go unnoticed, or unrealized.
Finding Savings Opportunities Is One Thing. Acting on Them Is Another.
Just because a more affordable medication is available doesn't mean people know about it.
Members may not realize they have other options, and their doctors may not know what those alternatives would cost under their insurance. As a result, opportunities to save can easily go unnoticed.
Consider a Scripta member living with type 1 diabetes who was prescribed NovoLog insulin. Scripta identified a more affordable insulin alternative and helped the member explore that option with their doctor, who approved the change based on the member’s treatment needs.
The result? The switch was projected to cut the health plan's monthly cost for that prescription by 50%.
For the member, it meant having another treatment option that met their medical needs. For the health plan, it meant an opportunity to spend significantly less on that prescription.
That's the difference Scripta can make: Helping people discover more affordable options and giving them the support to do something about it.
How Rx Navigation Turns Opportunities Into Savings
Finding a lower-cost prescription option is a good start. But what happens next?
Scripta Insights' doctor-driven, AI-powered Rx Navigation™ helps employers and health plans go beyond identifying potential savings by giving members the information and support they need to act on them. Here's how:
Identify potential savings. Scripta analyzes prescription information to uncover lower-cost, clinically appropriate options, whether through a different pharmacy, a medication alternative, or another available purchasing option.
Make savings opportunities actionable. Members receive personalized information about their prescription options and potential out-of-pocket savings, helping them make more informed decisions.
Engage prescribing providers. Scripta helps bring lower-cost, clinically appropriate medication alternatives to prescribing providers' attention and supports members who want to explore a change through its Help Me Switch feature. Prescribers review the options and make the final clinical decision.
Measure realized savings. When members successfully switch to lower-cost options, employers and health plans can realize measurable cost reductions. Depending on the prescription and benefit design, members may also save on out-of-pocket costs.
By connecting the right information with the people who can act on it, Rx Navigation helps turn potential savings into measurable results.
Are You Getting the Most Value From Your Diabetes Medication Spend?
GLP-1s may be getting the headlines, but they're only part of the picture. For employers and health plans, meaningful savings opportunities may already exist across the diabetes medications members rely on every day.
Realizing those savings requires more than identifying lower-cost options. It also requires helping members and their prescribing providers take the next step.
This American Diabetes Month, take a closer look at your pharmacy benefits. Are you getting the most value from the coverage you already provide, both for your plan and your members?
With Scripta's Rx Navigation, you can uncover opportunities to reduce pharmacy spend while helping members access more affordable, clinically appropriate prescriptions.




Comments